Luspatercept Alternatives Compared
Luspatercept | Vidaza (azacitidine) | Reblozyl (luspatercept) |
|
---|
Luspatercept | Vidaza (azacitidine) | Reblozyl (luspatercept) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Myelodysplastic Syndrome, Beta Thalassemia, Anemia. Luspatercept may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Myelodysplastic Syndrome. Vidaza may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Myelodysplastic Syndrome, Beta Thalassemia, Anemia. Reblozyl may also be used for purposes not listed in this medication guide. |
Related suggestions Myelodysplastic Syndrome
|
|||||||||||||||
More about Luspatercept | More about Vidaza (azacitidine) | More about Reblozyl (luspatercept) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Luspatercept has an average rating of 8.0 out of 10 from a total of 10 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 0% reported a negative effect. |
Vidaza has an average rating of 5.5 out of 10 from a total of 13 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 38% reported a negative effect. |
Reblozyl has an average rating of 9.2 out of 10 from a total of 6 ratings on Drugs.com. 83% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
View all Luspatercept side effects |
View all Vidaza side effects |
View all Reblozyl side effects |
||||||||||||||||
Drug Class | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
N/A |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Vidaza prices |
View all Reblozyl prices |
||||||||||||||||
Dosage Forms | ||||||||||||||||||
N/A |
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Reblozyl | Other azacitidine brands include: Onureg |
N/A |
||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
264 hours |
0.82 hours |
264 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 3 drugs are known to interact with Luspatercept:
|
A total of 181 drugs are known to interact with Vidaza:
|
A total of 3 drugs are known to interact with Reblozyl:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
November 08, 2019 |
N/A |
November 08, 2019 |
||||||||||||||||
WADA Class View classifications | ||||||||||||||||||
N/A |
||||||||||||||||||
More Information | ||||||||||||||||||
Patient Resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Procrit
Procrit is a man-made protein used to treat anemia caused by chronic kidney disease, chemotherapy ...
Reblozyl
Reblozyl is used to treat transfusion-dependent anemia in adults with ...
Vidaza
Vidaza is used to treat certain types of bone marrow cancers and blood cell disorders. Learn about ...
Tibsovo
Tibsovo (ivosidenib) is a once-daily oral medication that targets a specific gene mutation called ...
Dacogen
Dacogen (decitabine) is used to treat myelodysplastic syndromes (certain types of blood or bone ...
Inqovi
Inqovi (decitabine and cedazuridine) is used for the treatment of myelodysplastic syndromes (MDS) ...
Rytelo
Rytelo (imetelstat) is an injectable telomerase inhibitor that may be used to treat adults with ...
Onureg
Onureg (azacitidine) is used for the continued treatment of adult patients with acute myeloid ...
Ivosidenib
Ivosidenib is used for acute myeloid leukemia, biliary tract tumor, myelodysplastic syndrome
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.